CAS 129318-43-0
:Alendronate sodium
Description:
Alendronate sodium is a bisphosphonate medication primarily used to treat osteoporosis and other conditions that lead to bone loss. It functions by inhibiting osteoclast-mediated bone resorption, thereby increasing bone mineral density. The substance is typically administered orally and is characterized by its high solubility in water, which facilitates its absorption in the gastrointestinal tract. Alendronate sodium is a white to off-white crystalline powder, and it is stable under normal conditions but sensitive to moisture and light. Its molecular structure includes a phosphonate group, which is essential for its biological activity. The compound is often formulated as a sodium salt to enhance its stability and solubility. Common side effects may include gastrointestinal discomfort, and it is generally recommended to be taken on an empty stomach to maximize absorption. Due to its mechanism of action, alendronate sodium is also studied for potential applications in other metabolic bone diseases. Proper administration and adherence to guidelines are crucial for its effectiveness and to minimize adverse effects.
Formula:C4H13NO7P2·Na
InChI:InChI=1S/C4H13NO7P2.Na/c5-3-1-2-4(6,13(7,8)9)14(10,11)12;/h6H,1-3,5H2,(H2,7,8,9)(H2,10,11,12);
InChI key:InChIKey=NLILQNGSPQHASV-UHFFFAOYSA-N
SMILES:C(P(=O)(O)O)(P(=O)(O)O)(CCCN)O.[Na]
Synonyms:- (4-Amino-1-hydroxybutylidene) bisphosphonic acid monosodium salt
- 4-Amino-1-Hydroxy-1-Phosphonobutyl Phosphonic Acid, Monosodium
- 4-Amino-1-hydroxy-1,1-butanediphosphonic acid monosodium salt
- 4-Amino-1-hydroxybutylidene-1,1-bisphosphonic acid monosodium salt
- Alend
- Alendronate
- Alendronic acid monosodium salt
- Alenmax
- Bifosa
- Bonalon
- Eucalen
- Fosalan
- Fosamac
- Fosamax
- Indrol
- Mavil
- Mk-217
- Monosodium (4-amino-1-hydroxybutane-1,1-diyl)bisphosphonate
- Monosodium alendronate
- NeoBon
- Onclast
- Osteovan
- Phosphonic acid, (4-amino-1-hydroxybutylidene)bis-, monosodium salt
- Phosphonic acid, P,P′-(4-amino-1-hydroxybutylidene)bis-, sodium salt (1:1)
- Sodium 4-amino-1-hydroxy-1-phosphonobutane-1-phosphonate
- Sodium Alendronate
- See more synonyms
Sort by
Purity (%)
0
100
|
0
|
50
|
90
|
95
|
100
Found 8 products.
Phosphonic acid, (4-amino-1-hydroxybutylidene)bis-, monosodium salt
CAS:Formula:C4H13NNaO7P2Purity:98%Color and Shape:SolidMolecular weight:272.0858Alendronate monosodium
CAS:<p>Alendronate monosodium</p>Purity:98% 16-17%H2OMolecular weight:271.08g/molAlendronic Acid Sodium Salt
CAS:Formula:C4H12NO7P2·NaColor and Shape:White To Off-White SolidMolecular weight:248.09 22.99Alendronate sodium
CAS:<p>Blocks farnesyl diphosphate synthase (IC50 = 460 nM), induces macrophage apoptosis, halts osteoclast sterol synthesis.</p>Formula:C4H13NNaO7P2Purity:98%Color and Shape:SolidMolecular weight:272.09Alendronate Sodium Trihydrate
CAS:Formula:C4H12NNaO7P2·3H2OPurity:>97.0%(T)Color and Shape:White to Almost white powder to crystalMolecular weight:325.13Sodium hydrogen (4-amino-1-hydroxy-1-phosphonobutyl)phosphonate
CAS:Purity:95.0%Color and Shape:Solid, White - Almost white powderMolecular weight:271.0769958496094Alendronic Acid-d6 Sodium Salt Hydrate
CAS:Controlled Product<p>Applications Alendronic Acid-d6 Sodium Salt is a labelled salt analogue of Alendronic Acid (A521250), a bisphosphonate used as a bone reabsoption inhibitor.<br>References Wang, X.M., et al.: Clin. J. Dent. Res., 3, 26 (2000); Woo, T., et al.: Best Pract. Res. Clin. Rheumatol., 15, 469 (2001); Benford, H.L., et al.: Bone, 28, 465 (2001)<br></p>Formula:C4H6D6NNaO7P2xH2OColor and Shape:NeatMolecular weight:277.11








